Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

Retrospective study; Spanish Paediatric HIV Network; Rates of perinatal HIVEstudio retrospectivo; Red Española de VIH Pediátrico; Tasas de VIH perinatalEstudi retrospectiu; Xarxa espanyola de VIH Pediàtrica; Taxes de VIH perinatalBackground: There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods: A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results: A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions: A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact.This work has been partially funded by Red Temática de Investigación en SIDA (RED RIS) supported by Instituto de Salud Carlos III (ISCIII) (RD12/0017/0035, RD12/0017/0037 and RD16/0025/0019), project as part of the Plan R+D+I (2008-2011; 2013-2016) and cofinanced by ISCIII Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER), RISEPICLIN-19/2015, Fondo para la Investigación Sanitaria of the Spanish Ministry of Science and Innovation (FIS PI13/00422, PI16/01863), CYTED (214RT0482) and EPIICAL Project. CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, the Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. COST CA17140 Cancer Nanomedicine-Front The Bench to Bebside. We thank the Spanish HIV HGM BioBank supported by ISC III project RETIC PT13/0010/0028 and PT17/0015/0042. No funding for this work was received from National Institutes of Health (NIH), Wellcome Trust and Howard Hughes Medical Institute (HHMI

INTERAÇÕES ENTRE FÁRMACOS E ALIMENTOS

O tratamento de várias patologias pode ser realizado com algumas drogas, sendo que ao longo dos tratamentos podem ocorrer a interações entre essas drogas e alguns tipos de alimentos, visto que os fármacos apresentam a capacidade de interagir com os alimentos quando são ingeridas simultaneamente, essas interações são capazes de causar efeitos que possam atrapalhar a pratica terapêutica, como a alteração na farmacologia da droga, causando a inefetividade do medicamento, aumentando as chances de ocorrer efeitos adversos, aumentando a velocidade da absorção, e conseguem também afetar o estado nutricional do paciente, e essas interações podem ser decorrentes de uma relação física, química e fisiológica. O objetivo desse trabalho é apresentar para a população e profissionais da área da saúde os riscos causados pela interação fármaco-alimento, e mostrar a importância da ingestão dos fármacos com os alimentos corretos, para que possa ocorrer o melhor resultado do tratamento terapêutico. Foi realizada uma pesquisa bibliográfica através de artigos científicos, com base nessa pesquisa obtivemos os seguintes resultados: o paracetamol, quando ingerido com vitamina D ocorre à inativação dessa vitamina, desta forma recomenda-se tomar a vitamina D duas horas antes da ingestão do fármaco, o captopril quando ingerido com alimentos em geral, diminuem a absorção do fármaco em 30 a 40%, recomenda-se administrar o fármaco uma hora antes ou duas horas depois das refeições, são esses alguns exemplos simples dessas interações, que ainda é um assunto bastante desconhecido ou ignorado por a população e alguns profissionais da área da saúde, sendo assim necessária a orientação dessas pessoas sobre os riscos que as interações podem oferecer. Podemos assim concluir que esse ainda é um assunto que está sendo cada vez mais relevante, mas que ainda é desconhecido por muitas pessoas, é muito importante que essas pessoas, principalmente os profissionais da área da saúde tomem conhecimento sobre esse assunto e possam criar programas educacionais para que seus pacientes saibam como fazer o uso correto dos fármacos com os alimentos, e no horário certo

ME20-S as a Potential Biomarker for the Evaluation of Uveal Melanoma

PURPOSE: We previously identified the presence of the melanocyte-specific secreted (ME20-S) glycoprotein in secretomes of uveal melanoma (UM) cultures. The aim of this study was to test for the presence and levels of ME20-S in the serum of patients with choroidal nevi and UM and correlate these levels with individual clinical data. METHODS: Serum ME20-S levels were determined by ELISA in 111 patients distributed into four categories (53 choroidal nevi, 30 untreated UM, 11 10-year disease-free [DF] UM, 17 hepatic metastatic UM) and 32 age- and sex-matched controls. ME20-S levels were correlated with individual clinical data. RESULTS: The UM and the metastatic groups showed significantly higher levels of serum ME20-S than the other groups (P < 0.001). ME20-S levels in the DF patients did not differ from those in the control group. In addition, log-transformed serum ME20-S levels showed a positive correlation with the thickness of the lesion mass in UM patients (regression coefficient 0.0689, 95% confidence interval 0.0689-0.1123, R2 = 27.1%). CONCLUSIONS: Elevated ME20-S serum levels are associated with tumor size and advanced stages of UM while low levels are characteristic of DF patients. ME20-S might be a promising serum marker for UM and useful for monitoring metastatic disease

New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013

Vertical human immunodeficiency virus (HIV) infection has decreased in industrialized countries in recent decades, but there are no studies on the mechanisms of HIV transmission among infected children in Spain. Our aim was to study the characteristics and trends of diagnoses of vertically HIV-infected children in Spain from 2004 to 2013. Vertically HIV-infected children were selected if they were diagnosed from 2004 to 2013, were aged 0 to 18 years old, and were included in the Cohort of the Spanish Pediatric HIV Network (CoRISpe). Demographic, clinical, immunological, and virological data at diagnosis were obtained. The rate of diagnoses of vertically HIV-infected children was calculated as the number of cases per 100,000 inhabitants. Obstetric data of mothers of Spanish children and prophylaxis at childbirth and postpartum were obtained. A total of 218 HIV-infected children were included in the study. Of this sample, 182 children (83.5%) were perinatally HIV infected, and 125 out of those 182 children (68.7%) were born in Spain. The vertically HIV-infected Spanish children were diagnosed earlier and were in better clinical and immunological condition at diagnosis than were foreign children. The rate of vertically HIV-infected children declined from 0.09 in 2004 to 0.03 in 2013 due to the decrease in the rate of children born in Spain (0.08 in 2004 vs 0.01 in 2013). A total of 60 out of 107 mothers (56.1%) of Spanish children were diagnosed at or after childbirth. However, this number declined between 2004 and 2013. The rate of new HIV diagnoses of vertically HIV-infected children decreased significantly between 2004 and 2013 from 0.09 to 0.03 per 100,000 inhabitant

New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013

Vertical human immunodeficiency virus (HIV) infection has decreased in industrialized countries in recent decades, but there are no studies on the mechanisms of HIV transmission among infected children in Spain. Our aim was to study the characteristics and trends of diagnoses of vertically HIV-infected children in Spain from 2004 to 2013. Vertically HIV-infected children were selected if they were diagnosed from 2004 to 2013, were aged 0 to 18 years old, and were included in the Cohort of the Spanish Pediatric HIV Network (CoRISpe). Demographic, clinical, immunological, and virological data at diagnosis were obtained. The rate of diagnoses of vertically HIV-infected children was calculated as the number of cases per 100,000 inhabitants. Obstetric data of mothers of Spanish children and prophylaxis at childbirth and postpartum were obtained. A total of 218 HIV-infected children were included in the study. Of this sample, 182 children (83.5%) were perinatally HIV infected, and 125 out of those 182 children (68.7%) were born in Spain. The vertically HIV-infected Spanish children were diagnosed earlier and were in better clinical and immunological condition at diagnosis than were foreign children. The rate of vertically HIV-infected children declined from 0.09 in 2004 to 0.03 in 2013 due to the decrease in the rate of children born in Spain (0.08 in 2004 vs 0.01 in 2013). A total of 60 out of 107 mothers (56.1%) of Spanish children were diagnosed at or after childbirth. However, this number declined between 2004 and 2013. The rate of new HIV diagnoses of vertically HIV-infected children decreased significantly between 2004 and 2013 from 0.09 to 0.03 per 100,000 inhabitants

Current extent of agroforestry in Europe

info:eu-repo/semantics/publishedVersio

East Asia Today

East Asia attracts growing interest in the West. Th e region is the world’s hotbed of economic growth, led by burgeoning China aided by more advanced Asian economies investing heavily in manufacturing and trading networks involving China. Western entrepreneurs clamor to join the China wave

High drug resistance prevalence among vertically HIV-Infected patients transferred from pediatric care to adult units in Spain

BACKGROUND: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children. METHODS: Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid. RESULTS: One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had ≤200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%). CONCLUSION: Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units

Current extent and stratification of agroforestry in the European Union

An accurate and objective estimate on the extent of agroforestry in Europe is critical for the development of supporting policies. For this reason, a more harmonised and uniform Pan-European estimate is needed. The aim of this study was to quantify and map the distribution of agroforestry in the European Union. We classified agroforestry into three main types of agroforestry systems: arable agroforestry, livestock agroforestry and high value tree agroforestry. These three classes are partly overlapping as high value tree agroforestry can be part of either arable or livestock agroforestry. Agroforestry areas were mapped using LUCAS Land Use and Land Cover data (Eurostat, 2015). By identifying certain combinations of primary and secondary land cover and/or land management it was possible to identify agroforestry points and stratify them in the three different systems. According to our estimate using the LUCAS database the total area under agroforestry in the EU 27 is about 15.4 million ha which is equivalent to about 3.6% of the territorial area and 8.8% of the utilised agricultural area. Of our three studied systems, livestock agroforestry covers about 15.1 million ha which is by far the largest area. High value tree agroforestry and arable agroforestry cover 1.1 and 0.3 million ha respectively. Spain (5.6 million ha), France (1.6 million ha), Greece (1.6 million ha), Italy (1.4 million ha), Portugal (1.2 million ha), Romania (0.9 million ha) and Bulgaria (0.9 million ha) have the largest absolute area of agroforestry. However the extent of agroforestry, expressed as a proportion of the utilised agricultural area (UAA), is greatest in countries like Cyprus (40% of UAA), Portugal (32% of UAA) and Greece (31% of UAA). A cluster analysis revealed that a high abundance of agroforestry areas can be found in the south-west quadrat of the Iberian Peninsula, the south of France, Sardinia, south and central Italy, central and north-east Greece, south and central Bulgaria, and central Romania. Since the data were collected and analysed in a uniform manner it is now possible to make comparisons between countries and identify regions in Europe where agroforestry is already widely practiced and areas where there are opportunities for practicing agroforestry on a larger area and introducing novel practices. In addition, with this method it is possible to make more precise estimates on the extent of agroforestry in Europe and changes over time. Because agroforestry covers a considerable part of the agricultural land in the EU, it is crucial that it gets a more prominent and clearer place in EU statistical reporting in order to provide decision makers with more reliable information on the extent and nature of agroforestry. Reliable information, in turn, should help to guide policy development and implementation, and the evaluation of the impact of agricultural and other policies on agroforestry